Health2 months ago
Regeneron Achieves Milestone in Phase 3 Trial for Rare Disorder
Regeneron Pharmaceuticals announced on October 25, 2023, that its investigational treatment, garetosmab, successfully met the primary endpoint in a Phase 3 clinical trial. This trial focused...
